v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current Assets:    
Cash $ 23,802 $ 228,540
Receivables and prepaid expenses 211,131 10,234
Total Current Assets 234,933 238,774
Non-current Assets:    
Property and equipment at cost, net of accumulated depreciation 18,848 20,162
Total Assets 253,781 258,936
Current Liabilities:    
Accounts payable 101,747 113,585
Accrued expenses and other payables 383,584 292,548
Convertible promissory notes, net 1,584,358 1,308,229
Derivative liability 789,788 722,192
Registration Rights Agreement liability 520,000 520,000
Total Current Liabilities 3,379,477 2,956,554
Non-current Liabilities:    
Accrued severance 186,681 176,093
Total Liabilities 3,566,158 3,132,647
Commitments and Contingencies (Note 7)
Stockholders’ Deficit    
Preferred A Stock, $0.0001 par value, 12,500,000 shares authorized; 5,847,937 shares outstanding at March 31, 2026 and December 31, 2025, respectively 585 585
Common stock, $0.0001 par value; 3,254,475,740 shares authorized; 976,997,116 and 956,997,116 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 97,699 95,699
Additional paid-in capital 19,279,548 19,081,548
Accumulated deficit (22,690,209) (22,051,543)
Total Stockholders’ Deficit (3,312,377) (2,873,711)
Total Liabilities and Stockholders’ Deficit $ 253,781 $ 258,936